digest
Short Summary
Main recommendation: Vitamin K2 (MK7 form) taken with vitamin D3 and a fat-containing meal may help slow arterial calcification, but the speaker frames the real goal as changing the type of plaque being built, not lowering the calcium score alone. The speaker argues that the calcium score can mislead, since dense, stable calcium can raise the number while spotty, inflamed calcium is the more dangerous kind. The video also includes a product promotion, which should be weighed with that in mind.
Key Points
- A calcium score combines two kinds of calcification: small, scattered specks inside hot, inflamed plaque (the more dangerous kind) and large, dense deposits that represent sealed, stable scarring.
- The 2025 Vit KAC trial (JAMA Cardiology, 168 people with symptomatic coronary artery disease, most already on statins) found calcium rose 69 points in the placebo group versus 49 points in the MK7 group over two years, about 29% less buildup. The study authors called the effect modest and raised the possibility that slowing calcification might not necessarily be a good thing.
- K2 works by activating matrix GLA protein (MGP), the body's main calcification inhibitor, which is made in an inactive form and needs vitamin K to function. The speaker says K2 does not pull calcium out of arteries into bone.
- Supporting evidence cited includes a Dutch warfarin study (visible arterial calcification in 14 of 19 warfarin users vs. 4 of 18 controls) and the Rotterdam study linking higher K2 intake to lower coronary death risk.
- The speaker addresses claims that K2 fixes insulin resistance (based on a high-dose MK4 trial in healthy young men) and says these are misleading; when 360 mcg MK7 was tested in type 2 diabetics for 12 weeks, insulin resistance markers did not change, so K2 is not an insulin resistance supplement.
Details Worth Noting
- Concrete instructions: Take vitamin K2 as MK7 (360 micrograms per day, the amount used in the JAMA trial; the speaker notes a Danish trial used 720 micrograms) together with vitamin D3, taken with a meal containing fat rather than on an empty stomach. The speaker says people on warfarin or any medication should speak to a doctor before making changes, and that this is not medical advice.
- Concrete instructions: Ask a doctor to test fasting insulin and keep it under five; test triglycerides and HDL and keep the triglyceride-to-HDL ratio at or below 1.5.
- Concrete instructions: Remove processed junk food and rancid vegetable oils (processed vegetable and seed oils); replace them with butter, ghee, coconut oil, and extra virgin olive oil; favor single-ingredient whole foods; improve sleep and manage stress.
- Concrete instructions: Do not treat the calcium score as a scoreboard. It cannot show soft plaque; a CT angiogram or coronary ultrasound shows the artery wall directly.
- The MESA study (3,398 participants) found that for a given calcium amount, denser calcium was linked to lower risk (hazard ratio 0.73 for coronary events, 0.71 for overall cardiovascular disease).
- The speaker notes that the product promoted in the video uses MK7 from fermentation of Bacillus subtilis natto, and states it has no fillers and is third-party tested. These are the speaker's claims, and the video includes a discount offer and a money-back guarantee tied to the speaker's promotion.
Bottom Line
The video presents K2 as a modest, mechanism-based support for calcification control, best viewed as part of a broader plan that targets inflammation, insulin, and diet rather than a standalone fix, with the calcium score interpreted cautiously.
